Skip to content
★ Sign in to follow
JC
Total declarations
178
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (55 ops.)
€19.5M

Latest filing published 03 Mar 2015 for Abbott Laboratories, €490k.

Insider track record

Disclosed buys
0
Disclosed sells
55
Signal history

No signal scores available.

John C. Landgraf: trading record in brief

This profile gathers the share dealings of John C. Landgraf in Abbott Laboratories. Over a trading history stretching from 1 December 2005 to 27 February 2015, the count stands at 178 filings.

Every open-market trade on record is a sale: 55 sales worth €19.5M. Outside the open market, there are 50 share grants and 46 option exercises.

The newest entry dates from 3 March 2015: a share grant of €490k, in Abbott Laboratories. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to John C. Landgraf

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations168 total
  • ◆
    Executive Vice PresidentExecutivesAbbott Laboratories
    548,943 USD0SEC
    11,530 shares@ US$47.61Common shares without par valueSEC:0001179110-15-004024:0
  • ◆
    Executive Vice PresidentExecutivesAbbott Laboratories
    0SEC
    23,457 shares0Common shares without par valueSEC:0001179110-15-003321:0
  • ◆
    Executive Vice PresidentExecutivesAbbott Laboratories
    648,302 USD0SEC
    16,289 shares@ US$39.80Common shares without par valueSEC:0001179110-15-003320:0
  • ◇
    Executive Vice PresidentExecutivesAbbott Laboratories
    196,343 USD0SEC
    6,247 shares@ US$31.43Common shares without par valueSEC:0001179110-14-009848:0
  • ◇
    Executive Vice PresidentExecutivesAbbott Laboratories
    384,505 USD0SEC
    11,956 shares@ US$32.16Common shares without par valueSEC:0001179110-14-009848:1
  • ◆
    Executive Vice PresidentExecutivesAbbott Laboratories
    648,103 USD0SEC
    16,284 shares@ US$39.80Common shares without par valueSEC:0001179110-14-009848:2
  • ◆
    Executive Vice PresidentExecutivesAbbott Laboratories
    609,066 USD0SEC
    15,307 shares@ US$39.79Common shares without par valueSEC:0001179110-14-004294:0
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    338,976 USD0SEC
    8,610 shares@ US$39.37Common shares without par valueSEC:0001179110-14-004294:1
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    54,226 USD0SEC
    1,377 shares@ US$39.38Common shares without par valueSEC:0001179110-14-004294:2
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    7,563 USD0SEC
    192 shares@ US$39.39Common shares without par valueSEC:0001179110-14-004294:3
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    248,496 USD0SEC
    6,307 shares@ US$39.40Common shares without par valueSEC:0001179110-14-004294:4
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    31,796 USD0SEC
    807 shares@ US$39.40Common shares without par valueSEC:0001179110-14-004294:5
  • ◆
    Executive Vice PresidentExecutivesAbbott Laboratories
    0SEC
    25,310 shares0Common shares without par valueSEC:0001179110-14-003631:0
  • ◇
    Executive Vice PresidentExecutivesAbbott Laboratories
    55,452 USD0SEC
    1,583 shares@ US$35.03Common Shares without par valueSEC:0001179110-14-003112:0
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    38,435 USD0SEC
    983 shares@ US$39.10Common Shares without par valueSEC:0001179110-14-003112:1
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    23,466 USD0SEC
    600 shares@ US$39.11Common Shares without par valueSEC:0001179110-14-003112:2
  • ◇
    Executive Vice PresidentExecutivesAbbott Laboratories
    706,620 USD0SEC
    21,972 shares@ US$32.16Common Shares without par valueSEC:0001179110-14-002504:0
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    384,280 USD0SEC
    10,400 shares@ US$36.95Common Shares without par valueSEC:0001179110-14-002504:1
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    427,701 USD0SEC
    11,572 shares@ US$36.96Common Shares without par valueSEC:0001179110-14-002504:2
  • ●
    Executive Vice PresidentExecutivesAbbott Laboratories
    0SEC
    2,885 shares0Common shares without par valueSEC:0001179110-13-018458:0
  • ◆
    Executive Vice PresidentExecutivesAbbott Laboratories
    459,564 USD0SEC
    13,414 shares@ US$34.26Common shares without par valueSEC:0001179110-13-003902:0
  • ◆
    Executive Vice PresidentExecutivesAbbott Laboratories
    0SEC
    31,700 shares0Common shares without par valueSEC:0001179110-13-003141:0
  • ◆
    Executive Vice PresidentExecutivesAbbott Laboratories
    302,249 USD0SEC
    8,616 shares@ US$35.08Common shares without par valueSEC:0001179110-13-003141:1
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    97,384 USD0SEC
    2,800 shares@ US$34.78Common shares without par valueSEC:0001179110-13-003141:2
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    9,251 USD0SEC
    266 shares@ US$34.78Common shares without par valueSEC:0001179110-13-003141:3

25 of 168 declarations